ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Multimodal Therapy for Mesothelioma: An Exploration With Jeffrey Velotta and Joel Dunning
In this series, CTSNet invites top cardiothoracic surgeons from around the world to engage in in-depth discussions about important topics in the field of CT surgery by examining specific cases in detail. Watch for more insightful expert discussion videos in the coming weeks.
In this in-depth discussion, CTSNet Editor-in-Chief Dr. Joel Dunning and Dr. Jeffrey Velotta, Assistant Clinical Professor of Surgery at UCSF School of Medicine and thoracic surgeon at Kaiser Permanente Oakland Medical Center, examine multimodal therapy for mesothelioma.
They explore the survival benefits of this approach and discuss a real-life case of a patient with malignant mesothelioma. Topics covered include extrapleural dissection, visceral pleural removal, cryoablation for pleural nerves, nodal dissection, peeling off the visceral pleura, diaphragm muscle, visceral pleurectomy, diaphragm reconstruction, and more. Dr. Velotta also provides a preview of the upcoming guidelines for multimodal therapy for mesothelioma following the MARS-2 trial and discusses the process of creating these guidelines.
Related Resources
- Comparison of Survival by Multimodal Treatment Regimen Among Malignant Pleural Mesothelioma Patients in an Integrated Health System
- Improving Outcomes in Malignant Pleural Mesothelioma in an Integrated Health Care System
Disclaimer
The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.
Printer-friendly
